WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: MYRISK HEREDITARY CANCER TEST

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on MYRISK HEREDITARY CANCER TEST

Mark Identification

Proof of use for MYRISK HEREDITARY CANCER TEST

We do not have any records of a proof of use for MYRISK HEREDITARY CANCER TEST at this moment.

Click here to add a proof of use for MYRISK HEREDITARY CANCER TEST

Possible trademark infringements of MYRISK HEREDITARY CANCER TEST

Basic Information about MYRISK HEREDITARY CANCER TEST

Serial Number
99006549
Filing Date
17 Jan 2025
Mark Drawing Code
3

Classifications

Declare the trademark use of MYRISK HEREDITARY CANCER TEST on the blockchain with WikiTrademarks.io.

First use of MYRISK HEREDITARY CANCER TEST anywhere
MYRISK HEREDITARY CANCER TEST was first used on 05 Nov 2021 for the primary classification of goods and services, international, 010 (Medical Apparatus)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
010
US Codes
026; 039; 044

Who owns MYRISK HEREDITARY CANCER TEST?

1. Myriad Genetics, Inc. Salt Lake City UT

Correspondent

Katherine P. Califa Foley & Lardner LLP
3000 K Street, N.W.
Sixth Floor
Washington, DC 20007

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on MYRISK HEREDITARY CANCER TEST